The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery.
Angela CollarinoRenato A Valdés OlmosLotta G A J van BerkelPeter A NeijenhuisLidy M H WijersFrederik SmitLioe-Fee de Geus-OeiLenka M Pereira Arias-BoudaPublished in: Breast cancer research and treatment (2018)
MBI seems to be a useful imaging modality with a high predictive value in revealing ipsilateral and bilateral disease not visualized by mammography and ultrasound. It may play an important role in delineating the extent of the index lesion during preoperative planning. Incorporation of MBI in the clinical work-up as an adjunct modality to mammography and ultrasound may lead to better selection of patients who could benefit from BCS.
Keyphrases
- high resolution
- magnetic resonance imaging
- contrast enhanced
- minimally invasive
- patients undergoing
- coronary artery bypass
- image quality
- squamous cell carcinoma
- magnetic resonance
- ultrasound guided
- computed tomography
- neoadjuvant chemotherapy
- contrast enhanced ultrasound
- fluorescence imaging
- lymph node
- photodynamic therapy
- percutaneous coronary intervention
- mass spectrometry